Literature DB >> 26721498

Analyzing MiRNA-LncRNA Interactions.

Maria D Paraskevopoulou1, Artemis G Hatzigeorgiou2.   

Abstract

Long noncoding RNAs (lncRNAs) are noncoding transcripts usually longer than 200 nts that have recently emerged as one of the largest and significantly diverse RNA families. The biological role and functions of lncRNAs are still mostly uncharacterized. Their target-mimetic, sponge/decoy function on microRNAs was recently uncovered. miRNAs are a class of noncoding RNA species (~22 nts) that play a central role in posttranscriptional regulation of protein coding genes by mRNA cleavage, direct translational repression and/or mRNA destabilization. LncRNAs can act as miRNA sponges, reducing their regulatory effect on mRNAs. This function introduces an extra layer of complexity in the miRNA-target interaction network. This chapter focuses on the study of miRNA-lncRNA interactions with either in silico or experimentally supported analyses. The proposed methodologies can be appropriately adapted in order to become the backbone of advanced multistep functional miRNA analyses.

Keywords:  Experimentally supported; HITS-CLIP; In-silico predictions; Interaction; PAR-CLIP; Sponge; lncRNA; microRNA

Mesh:

Substances:

Year:  2016        PMID: 26721498     DOI: 10.1007/978-1-4939-3378-5_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  289 in total

1.  Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140.

Authors:  Yuqin Ding; Qianjin Fang; Yan Li; Yanni Wang
Journal:  Mamm Genome       Date:  2019-06-20       Impact factor: 2.957

Review 2.  Re-evaluating Strategies to Define the Immunoregulatory Roles of miRNAs.

Authors:  Adriana Forero; Lomon So; Ram Savan
Journal:  Trends Immunol       Date:  2017-06-27       Impact factor: 16.687

3.  Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244.

Authors:  Ya Liu; Xiaocui He; Yuli Chen; Dan Cao
Journal:  Mol Cell Biochem       Date:  2019-11-05       Impact factor: 3.396

4.  Knocking down LINC01116 can inhibit the regulation of TGF-β through miR-774-5p axis and inhibit the occurrence and development of glioma.

Authors:  Jinfeng Lou; Pengfei Wang; Keliang Chang; Genwei Wang; Xiaoteng Geng; Yang Wu; Wanhong Zhang; Guangming Niu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 5.  Roles of miRNA and lncRNA in triple-negative breast cancer.

Authors:  Juan Xu; Kang-Jing Wu; Qiao-Jun Jia; Xian-Feng Ding
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

6.  Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1.

Authors:  Gang Wang; Jingen Pan; Lu Zhang; Yajun Wei; Cheng Wang
Journal:  Cell Prolif       Date:  2017-09-21       Impact factor: 6.831

7.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

8.  ZFAS1 knockdown inhibits fibroblast-like synoviocyte proliferation, migration, invasion and inflammation, and promotes apoptosis via miR-3926/FSTL1 in rheumatoid arthritis.

Authors:  Qiang Wang; Peigang Chu; Xia Yu; Jun Li; Wenzheng Zhang; Mingzhi Gong
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

9.  Analyses of long non-coding RNA and mRNA profiles in the spinal cord of rats using RNA sequencing during the progression of neuropathic pain in an SNI model.

Authors:  Jun Zhou; Youling Fan; Hongtao Chen
Journal:  RNA Biol       Date:  2017-09-29       Impact factor: 4.652

10.  LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5.

Authors:  Zhiyu Ye; Qikuan He; Qiaona Wang; Yunshou Lin; Kenan Cen; Xiaogang Chen
Journal:  Mol Cell Biochem       Date:  2021-06-07       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.